Finance

Lists
524372:BOM
Orchid Pharma Ltd
₹ ९३७.००
-१.१०%
(-१०.४५) 1D
अक्टोबर १५, १४:०१:४१ GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524372...
Open
₹ ९४५.०५
High
₹ ९४८.००
Low
₹ ९३४.३०
Mkt. cap
५६.०९ अरब
Avg. vol.
६.८८ हजार
Volume
३.२४ हजार
52-wk high
₹ १,१४२.६५
52-wk low
₹ ४७१.३०
No. of employees
१ हजार
Open
₹ ९४५.०५
High
₹ ९४८.००
Low
₹ ९३४.३०
Mkt. cap
५६.०९ अरब
Avg. vol.
६.८८ हजार
Volume
३.२४ हजार
52-wk high
₹ १,१४२.६५
52-wk low
₹ ४७१.३०
No. of employees
१ हजार
News stories
From web sources and news partners
Sun Herald
Sun Herald
·
३ मिनेट पहिले
Nasdaq futures dive 1% as AI rout deepens on debt concerns
Investing.com
Investing.com
·
१३ मिनेट पहिले
NYSE short interest hits record high in late September - report
ChartMill
ChartMill
·
१७ मिनेट पहिले
Stock Market Today: Hot Inflation and a Neocloud Shakeout Sink the Nasdaq
Yahoo Finance
Yahoo Finance
·
२३ मिनेट पहिले
US Stock Market Today: S&P 500 Futures Edge Up On Energy Driven Inflation Focus
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees१.१७ हजार
Founded१९९२
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.९४ अरब
२.०७ अरब
६.५९ अरब
३.०४ अरब
Cost of goods sold
१.३३ अरब
१.४३ अरब
५.०३ अरब
२.०४ अरब
Cost of revenue
१.३३ अरब
१.४३ अरब
५.०३ अरब
२.०४ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२४.८५ करोड
२४.१३ करोड
५०.२३ करोड
२८.०४ करोड
Operating expense
७१.३९ करोड
७१.५९ करोड
१.४० अरब
९६.८२ करोड
Total operating expenses
२.०४ अरब
२.१५ अरब
६.४३ अरब
३.०१ अरब
Operating income
-१०.३८ करोड
-७.४७ करोड
१६.३८ करोड
३.०५ करोड
Other non operating income
१०.७७ करोड
५.६१ करोड
-२३.८० करोड
१.८३ करोड
EBT including unusual items
-५.७२ करोड
-१२.६१ करोड
१३.१९ करोड
३.३० करोड
EBT excluding unusual items
-५.७२ करोड
-५.५० करोड
५.४९ करोड
३.३० करोड
Income tax expense
-
-
१७.०० हजार
७.२३ लाख
Effective tax rate
-
-
०.०१%
२.१९%
Other operating expenses
३७.६४ करोड
३८.४३ करोड
४१.९३ करोड
५७.८३ करोड
Net income
-५.७२ करोड
-१२.६१ करोड
१३.१९ करोड
३.२२ करोड
Net profit margin
-२.९६%
-६.०९%
२.००%
१.०६%
Earnings per share
-१.१३
-१.०८
४.५८
०.५४
Interest and investment income
-
-
१०.१२ करोड
-
Interest expense
-३.७३ करोड
-३.१८ करोड
-
-२.२३ करोड
Net interest expenses
-३.७३ करोड
-३.१८ करोड
१०.१२ करोड
-२.२३ करोड
Depreciation and amortization charges
८.९० करोड
९.०३ करोड
१६.६६ करोड
१०.९५ करोड
EBITDA
-१.६० करोड
१.०५ करोड
२६.९६ करोड
११.९१ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू